The Texas Heart Institute Cardiac Society Symposium is held every year in May, at the end of the academic season. This year’s meeting will be May 11, 2018.
The cardiovascular field is rapidly evolving. Within the last decade there has been tremendous advances in the field of transcatheter therapies to treat arrhythmia and valvular, congenital, coronary and peripheral vascular diseases. In the same time period we have witnessed the introduction of novel antithrombotic therapies for atrial fibrillation and deep venous thrombosis. Additionally, advances in the field of echocardiography, cardiac CT and MRI have improved risk assessments and become essential components of procedural planning for percutaneous interventions, particularly for structural heart disease.
This full day symposium will cover the history and future of cardiac surgery, current strategies in advanced heart failure, different approaches to peripheral interventions, the debate between medical management and coronary intervention, the cost-effectiveness of novel atherosclerotic therapy, and the optimal management of adult congenital heart disease.A panel of experts will review peripheral interventional cases, including technique and approach. A debate for coronary artery disease management will list the controversy based on prior literature and the recent ORBITA trial. The symposium will cover a broad range of topics including cardiac surgery, peripheral interventions, coronary heart disease management, advanced heart failure, and congenital heart disease.
Given the increasing complexity of our specialty and the focused scope of our medical meetings, physicians in training, physicians in practice and all associated health care personnel can find it difficult to participate in educational activities that cover the breath of cardiovascular medicine. This meeting hopes to provide members of the Texas Heart Institute Cardiac Society and other health professionals involved in cardiovascular care with an educational experience that is comprehensive and yet concentrated in a practical, one-day format. The meeting also provides a forum for exchange of ideas.
Target Audience
Our audience for this continuing medical education activity will include cardiologists and researchers with an interest in cardiovascular disease, especially arrhythmias and valvular, congenital, coronary and peripheral vascular diseases. Participants to include physicians, fellows, residents, physician assistants, pharmacists, nurses / nurse practitioners and medical students.
